Form 4 Filing for Nuvalent, Inc. - Insider Transaction

This filing details a Form 4 submission by Henry E. Pelish, Chief Scientific Officer of Nuvalent, Inc. On December 22, 2025, Mr. Pelish exercised a stock option to acquire 5,085 shares of Class A Common Stock at an exercise price of $1.08 per share. This transaction is marked as a derivative disposition ('D') with a market acquisition code ('M'). Following this exercise, Mr. Pelish's post-transaction shares related to this option are reported as 0. Concurrently, on the same date, Mr. Pelish acquired 5,085 shares of Class A Common Stock, indicated by an acquisition code ('A') and a market transaction code ('M'). His post-transaction ownership of Class A Common Stock is 71,048 shares. The underlying shares for the option are Class A Common Stock, and the option is exercisable until February 16, 2031. The option shares were fully vested as noted in footnote F1.